Skip to main content
. 2020 May 4;9(5):229. doi: 10.3390/antibiotics9050229

Figure 2.

Figure 2

A typical workflow for omics, integrating molecular, chemical, and computational science to elucidate the potential of microorganisms and molecules for therapeutics.

HHS Vulnerability Disclosure